{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:26:37Z","timestamp":1776381997739,"version":"3.51.2"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sfnmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.siny.2021.101322","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T12:42:30Z","timestamp":1640004150000},"page":"101322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Placental tissue stem cells and their role in neonatal diseases"],"prefix":"10.1016","volume":"27","author":[{"given":"Andreas","family":"Damianos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory T.","family":"Kalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir V.","family":"Kalinichenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.siny.2021.101322_bib1","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM198910263211707","article-title":"Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling","volume":"321","author":"Gluckman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.siny.2021.101322_bib2","volume":"vol. 10","author":"Behrman Re","year":"2007"},{"issue":"5","key":"10.1016\/j.siny.2021.101322_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jpeds.2013.11.036","article-title":"Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy","volume":"164","author":"Cotten","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.siny.2021.101322_bib4","series-title":"Yaffe and Aranda's neonatal and pediatric pharmacology","article-title":"Stem cells","author":"Young","year":"2020"},{"key":"10.1016\/j.siny.2021.101322_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpobgyn.2015.08.014","article-title":"Placental stem cells","volume":"31","author":"Antoniadou","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"173","key":"10.1016\/j.siny.2021.101322_bib6","article-title":"A review of placenta and umbilical cord-derived stem cells and the immunomodulatory basis of their therapeutic potential in bronchopulmonary dysplasia","volume":"9","author":"Chia","year":"2021","journal-title":"Front Pediatr"},{"issue":"3","key":"10.1016\/j.siny.2021.101322_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10616-014-9796-y","article-title":"Characteristics of hematopoietic stem cells of umbilical cord blood","volume":"67","author":"Hordyjewska","year":"2015","journal-title":"Cytotechnology"},{"issue":"5","key":"10.1016\/j.siny.2021.101322_bib8","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/sctm.16-0360","article-title":"Endothelial progenitors: a consensus statement on nomenclature","volume":"6","author":"Medina","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"9","key":"10.1016\/j.siny.2021.101322_bib9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1164\/rccm.201812-2312OC","article-title":"Postnatal alveologenesis depends on FOXF1 signaling in c-KIT(+) endothelial progenitor cells","volume":"200","author":"Ren","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.siny.2021.101322_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1164\/rccm.202003-0758OC","article-title":"Generation of pulmonary endothelial progenitor cells for cell-based therapy using interspecies mouse-rat chimeras","volume":"204","author":"Wang","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.siny.2021.101322_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1165\/rcmb.2021-0152TR","article-title":"Therapeutic potential of endothelial progenitor cells in pulmonary diseases","volume":"65","author":"Kolesnichenko","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1438","key":"10.1016\/j.siny.2021.101322_bib12","article-title":"Perinatal derivatives: where do we stand? A roadmap of the human placenta and consensus for tissue and cell nomenclature","volume":"8","author":"Silini","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"10.1016\/j.siny.2021.101322_bib13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1634\/stemcells.2007-0594","article-title":"Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells","volume":"26","author":"Parolini","year":"2008","journal-title":"Stem Cell"},{"key":"10.1016\/j.siny.2021.101322_bib14","series-title":"Human placenta-derived mesenchymal stromal cells: a review from basic research to clinical applications","author":"Paz de la Torre","year":"2018"},{"issue":"9","key":"10.1016\/j.siny.2021.101322_bib15","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/1933719116632924","article-title":"Phenotypic and functional characterization of mesenchymal stem\/multipotent stromal cells from decidua parietalis of human term placenta","volume":"23","author":"Abumaree","year":"2016","journal-title":"Reprod Sci"},{"key":"10.1016\/j.siny.2021.101322_bib16","first-page":"107836","article-title":"Amniotic fluid and amniotic membrane stem cells: marker discovery","volume":"2012","author":"Roubelakis","year":"2012","journal-title":"Stem Cell Int"},{"issue":"2","key":"10.1016\/j.siny.2021.101322_bib17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3349\/ymj.2013.54.2.416","article-title":"Long-term (postnatal day 70) outcome and safety of intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells in neonatal hyperoxic lung injury","volume":"54","author":"Ahn","year":"2013","journal-title":"Yonsei Med J"},{"issue":"127","key":"10.1016\/j.siny.2021.101322_bib18","first-page":"e56021","article-title":"Isolation of endothelial progenitor cells from human umbilical cord blood","author":"Au - Ravishankar","year":"2017","journal-title":"JoVE"},{"issue":"4","key":"10.1016\/j.siny.2021.101322_bib19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000497422","article-title":"Bronchopulmonary dysplasia: 50 Years after the original description","volume":"115","author":"Bancalari","year":"2019","journal-title":"Neonatology"},{"issue":"Suppl 3","key":"10.1016\/j.siny.2021.101322_bib20","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1513\/AnnalsATS.201312-424LD","article-title":"Bronchopulmonary dysplasia: NHLBI workshop on the primary prevention of chronic lung diseases","volume":"11","author":"McEvoy","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.siny.2021.101322_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jpeds.2018.01.043","article-title":"Bronchopulmonary dysplasia: executive summary of a workshop","volume":"197","author":"Higgins","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.siny.2021.101322_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fmed.2015.00049","article-title":"Animal models, learning lessons to prevent and treat neonatal chronic lung disease","volume":"2","author":"Jobe","year":"2015","journal-title":"Front Med"},{"issue":"12","key":"10.1016\/j.siny.2021.101322_bib23","doi-asserted-by":"crossref","first-page":"L936","DOI":"10.1152\/ajplung.00159.2014","article-title":"Animal models of bronchopulmonary dysplasia. The term mouse models","volume":"307","author":"Berger","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.siny.2021.101322_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41390-019-0425-5","article-title":"Stem cell therapy for preventing neonatal diseases in the 21st century: current understanding and challenges","volume":"87","author":"Nitkin","year":"2020","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.siny.2021.101322_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/sctm.19-0193","article-title":"Are all stem cells equal? Systematic review, evidence map, and meta-analyses of preclinical stem cell-based therapies for bronchopulmonary dysplasia","volume":"9","author":"Augustine","year":"2020","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"10.1016\/j.siny.2021.101322_bib26","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/sctm.17-0126","article-title":"Mesenchymal stromal cell therapy in bronchopulmonary dysplasia: systematic review and meta-analysis of preclinical studies","volume":"6","author":"Augustine","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"10.1016\/j.siny.2021.101322_bib27","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1016\/j.ajpath.2014.08.010","article-title":"Intranasal versus intraperitoneal delivery of human umbilical cord tissue-derived cultured mesenchymal stromal cells in a murine model of neonatal lung injury","volume":"184","author":"Liu","year":"2014","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.siny.2021.101322_bib28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pedneo.2020.05.012","article-title":"Human placenta-derived mesenchymal stem cells attenuate established hyperoxia-induced lung injury in newborn rats","volume":"61","author":"Chou","year":"2020","journal-title":"Pediatr Neonatol"},{"issue":"3","key":"10.1016\/j.siny.2021.101322_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1165\/rcmb.2013-0385OC","article-title":"Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury","volume":"51","author":"Chang","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.siny.2021.101322_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3727\/096368909788809857","article-title":"Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis","volume":"18","author":"Cargnoni","year":"2009","journal-title":"Cell Transplant"},{"issue":"21","key":"10.1016\/j.siny.2021.101322_bib31","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1161\/CIRCULATIONAHA.114.009124","article-title":"Existence, functional impairment, and lung repair potential of endothelial colony-forming cells in oxygen-induced arrested alveolar growth","volume":"129","author":"Alphonse","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.siny.2021.101322_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13287-017-0689-9","article-title":"Human amnion cells reverse acute and chronic pulmonary damage in experimental neonatal lung injury","volume":"8","author":"Zhu","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.siny.2021.101322_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1164\/rccm.201705-0925OC","article-title":"Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation","volume":"197","author":"Willis","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.siny.2021.101322_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13287-018-0903-4","article-title":"Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6","volume":"9","author":"Chaubey","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"10.1016\/j.siny.2021.101322_bib35","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","article-title":"Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial","volume":"164","author":"Chang","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.siny.2021.101322_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpeds.2017.02.061","article-title":"Two-year follow-up outcomes of premature infants enrolled in the phase I trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia","volume":"185","author":"Ahn","year":"2017","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.siny.2021.101322_bib37","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/sctm.20-0330","article-title":"Stem cells for bronchopulmonary dysplasia in preterm infants: a randomized controlled phase II trial","volume":"10","author":"Ahn","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.siny.2021.101322_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpeds.2019.02.029","article-title":"Safety of intratracheal administration of human umbilical cord blood derived mesenchymal stromal cells in extremely low birth weight preterm infants","volume":"210","author":"Powell","year":"2019","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.siny.2021.101322_bib39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/sctm.18-0079","article-title":"First-in-human administration of allogeneic amnion cells in premature infants with bronchopulmonary dysplasia: a safety study","volume":"7","author":"Lim","year":"2018","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"10.1016\/j.siny.2021.101322_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/sctm.19-0251","article-title":"Two-year outcomes of infants enrolled in the first-in-human study of amnion cells for bronchopulmonary dysplasia","volume":"9","author":"Malhotra","year":"2020","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"10.1016\/j.siny.2021.101322_bib41","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0002-9440(10)65000-6","article-title":"Dual-hit hypothesis explains pulmonary hypoplasia in the nitrofen model of congenital diaphragmatic hernia","volume":"156","author":"Keijzer","year":"2000","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.siny.2021.101322_bib42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jpedsurg.2019.10.033","article-title":"Congenital diaphragmatic hernia as a potential target for transamniotic stem cell therapy","volume":"55","author":"Chalphin","year":"2020","journal-title":"J Pediatr Surg"},{"issue":"5","key":"10.1016\/j.siny.2021.101322_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000515277","article-title":"Transamniotic stem cell therapy for experimental congenital diaphragmatic hernia: structural, transcriptional, and cell kinetics analyses in the nitrofen model","volume":"48","author":"Chalphin","year":"2021","journal-title":"Fetal Diagn Ther"},{"issue":"590","key":"10.1016\/j.siny.2021.101322_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax5941","article-title":"Fetal lung underdevelopment is rescued by administration of amniotic fluid stem cell extracellular vesicles in rodents","volume":"13","author":"Antounians","year":"2021","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.siny.2021.101322_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00383-018-4376-4","article-title":"Endoplasmic reticulum stress response is activated in pulmonary hypoplasia secondary to congenital diaphragmatic hernia, but is decreased by administration of amniotic fluid stem cells","volume":"35","author":"Tzanetakis","year":"2019","journal-title":"Pediatr Surg Int"},{"issue":"4","key":"10.1016\/j.siny.2021.101322_bib46","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.110.971622","article-title":"Characterization and functionality of cardiac progenitor cells in congenital heart patients","volume":"123","author":"Mishra","year":"2011","journal-title":"Circulation"},{"issue":"1\u20132","key":"10.1016\/j.siny.2021.101322_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11010-020-03750-6","article-title":"Small molecule 2'-deoxycytidine differentiates human umbilical cord-derived MSCs into cardiac progenitors in vitro and their in vivo xeno-transplantation improves cardiac function","volume":"470","author":"Ali","year":"2020","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"10.1016\/j.siny.2021.101322_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/scd.2010.0519","article-title":"5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase","volume":"21","author":"Qian","year":"2012","journal-title":"Stem Cell Dev"},{"issue":"9","key":"10.1016\/j.siny.2021.101322_bib49","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1582-4934.2010.01197.x","article-title":"Direct contact of umbilical cord blood endothelial progenitors with living cardiac tissue is a requirement for vascular tube-like structures formation","volume":"15","author":"Lupu","year":"2011","journal-title":"J Cell Mol Med"},{"issue":"11 Suppl","key":"10.1016\/j.siny.2021.101322_bib50","first-page":"I64","article-title":"Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source","volume":"116","author":"Schmidt","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.siny.2021.101322_bib51","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3727\/096368909X471170","article-title":"Autologous umbilical cord blood mononuclear cell transplantation preserves right ventricular function in a novel model of chronic right ventricular volume overload","volume":"18","author":"Yerebakan","year":"2009","journal-title":"Cell Transplant"},{"issue":"9","key":"10.1016\/j.siny.2021.101322_bib52","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/eurheartj\/ehi818","article-title":"A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction","volume":"27","author":"Freyman","year":"2006","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.siny.2021.101322_bib53","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.jtcvs.2019.06.001","article-title":"Autologous stem cell therapy for hypoplastic left heart syndrome: safety and feasibility of intraoperative intramyocardial injections","volume":"158","author":"Burkhart","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.siny.2021.101322_bib54","first-page":"Cd003311","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy","volume":"2013","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1016\/j.siny.2021.101322_bib55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/pr.2013.206","article-title":"Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990","volume":"74","author":"Lee","year":"2013","journal-title":"Pediatr Res"},{"issue":"78","key":"10.1016\/j.siny.2021.101322_bib56","article-title":"Neonatal hypoxia ischaemia: mechanisms, models, and therapeutic challenges","volume":"11","author":"Millar","year":"2017","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"10.1016\/j.siny.2021.101322_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063142","article-title":"Stem cell therapy for neonatal hypoxic-ischemic encephalopathy: a systematic review of preclinical studies","volume":"22","author":"Serrenho","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.siny.2021.101322_bib58","article-title":"Stem cell\u2010based interventions for the prevention of morbidity and mortality following hypoxic\u2010ischaemic encephalopathy in newborn infants","volume":"2018","author":"Bruschettini","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.siny.2021.101322_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102449","article-title":"Intranasal delivery of mesenchymal stromal cells protects against neonatal Hypoxic\u207bIschemic brain injury","volume":"20","author":"McDonald","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.siny.2021.101322_bib60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00441-012-1401-0","article-title":"Transplantation of human umbilical cord blood cells mediated beneficial effects on apoptosis, angiogenesis and neuronal survival after hypoxic-ischemic brain injury in rats","volume":"348","author":"Rosenkranz","year":"2012","journal-title":"Cell Tissue Res"},{"issue":"11","key":"10.1016\/j.siny.2021.101322_bib61","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/sctm.17-0074","article-title":"Long-term recovery after endothelial colony-forming cells or human umbilical cord blood cells administration in a rat model of neonatal hypoxic-ischemic encephalopathy","volume":"6","author":"Grandvuillemin","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"5, Supplement","key":"10.1016\/j.siny.2021.101322_bib62","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1016\/j.jcyt.2020.04.052","article-title":"Phase I trial of allogeneic umbilical cord tissue-derived mesenchymal stromal cells in neonates with hypoxic-ischemic encephalopathy","volume":"22","author":"Cotten","year":"2020","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.siny.2021.101322_bib63","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1038\/s41598-020-61311-9","article-title":"Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety","volume":"10","author":"Tsuji","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.siny.2021.101322_bib64","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamapediatrics.2013.866","article-title":"Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage","volume":"167","author":"Payne","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"9","key":"10.1016\/j.siny.2021.101322_bib65","first-page":"Cd013201","article-title":"Stem cell-based interventions for the prevention and treatment of germinal matrix-intraventricular haemorrhage in preterm infants","volume":"9","author":"Romantsik","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.siny.2021.101322_bib66","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3727\/096368916X694193","article-title":"Mesenchymal stem cells: the magic cure for intraventricular hemorrhage?","volume":"26","author":"Park","year":"2017","journal-title":"Cell Transplant"},{"issue":"12","key":"10.1016\/j.siny.2021.101322_bib67","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/sctm.17-0219","article-title":"Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase I dose-escalation clinical trial","volume":"7","author":"Ahn","year":"2018","journal-title":"STEM CELLS Transl Med"},{"issue":"6","key":"10.1016\/j.siny.2021.101322_bib68","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5966\/sctm.2014-0296","article-title":"Placental mesenchymal stromal cells rescue ambulation in ovine myelomeningocele","volume":"4","author":"Wang","year":"2015","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"10.1016\/j.siny.2021.101322_bib69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000506866","article-title":"Necrotizing enterocolitis: the future","volume":"117","author":"Neu","year":"2020","journal-title":"Neonatology"},{"key":"10.1016\/j.siny.2021.101322_bib70","doi-asserted-by":"crossref","first-page":"578984","DOI":"10.3389\/fped.2020.578984","article-title":"Stem cells as therapy for necrotizing enterocolitis: a systematic review and meta-analysis of preclinical studies","volume":"8","author":"Villamor-Martinez","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.siny.2021.101322_bib71","article-title":"Transamniotic stem cell therapy","volume":"ume 7","author":"Lazow","year":"2019"},{"issue":"1","key":"10.1016\/j.siny.2021.101322_bib72","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jpedsurg.2015.10.011","article-title":"Transamniotic stem cell therapy (TRASCET) mitigates bowel damage in a model of gastroschisis","volume":"51","author":"Feng","year":"2016","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.siny.2021.101322_bib73","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jpedsurg.2016.10.016","article-title":"Transamniotic stem cell therapy (TRASCET) in a leporine model of gastroschisis","volume":"52","author":"Feng","year":"2017","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.siny.2021.101322_bib74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jpedsurg.2019.09.049","article-title":"A comparison between placental and amniotic mesenchymal stem cells in transamniotic stem cell therapy for experimental gastroschisis","volume":"55","author":"Chalphin","year":"2020","journal-title":"J Pediatr Surg"},{"issue":"11","key":"10.1016\/j.siny.2021.101322_bib75","doi-asserted-by":"crossref","first-page":"L1273","DOI":"10.1152\/ajplung.00237.2015","article-title":"Revascularization of decellularized lung scaffolds: principles and progress","volume":"309","author":"Stabler","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"10.1016\/j.siny.2021.101322_bib76","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/mt.2012.37","article-title":"Stem cells and regenerative medicine in lung biology and diseases","volume":"20","author":"Lau","year":"2012","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.siny.2021.101322_bib77","doi-asserted-by":"crossref","first-page":"1601355","DOI":"10.1183\/13993003.01355-2016","article-title":"How to build a lung: latest advances and emerging themes in lung bioengineering","volume":"52","author":"De Santis","year":"2018","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.siny.2021.101322_bib78","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/resp.12102","article-title":"Can stem cells be used to generate new lungs? Ex vivo lung bioengineering with decellularized whole lung scaffolds","volume":"18","author":"Wagner","year":"2013","journal-title":"Respirology"},{"issue":"7","key":"10.1016\/j.siny.2021.101322_bib79","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/17476348.2019.1624163","article-title":"Lung tissue bioengineering for chronic obstructive pulmonary disease: overcoming the need for lung transplantation from human donors","volume":"13","author":"Skolasinski","year":"2019","journal-title":"Expet Rev Respir Med"},{"issue":"4","key":"10.1016\/j.siny.2021.101322_bib80","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1164\/rccm.201909-1836OC","article-title":"In vivo generation of lung and thyroid tissues from embryonic stem cells using blastocyst complementation","volume":"203","author":"Wen","year":"2021","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X2100130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X2100130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:46:04Z","timestamp":1761677164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X2100130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1744165X2100130X"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2021.101322","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placental tissue stem cells and their role in neonatal diseases","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2021.101322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101322"}}